Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02734771
Title A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Acronym BV mini CHP
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Patrick Reagan
Indications
Therapies
Age Groups: senior
Covered Countries USA


No variant requirements are available.